RHYTHM PHARMACEUTICALS, INC. (RYTM) Free cash flow 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$116.6MFY2025 · since FY2016: -$24.3M → -$116.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$116.6M | -2.4% |
| FY2024 | -$113.9M | +16.4% |
| FY2023 | -$136.2M | +21.6% |
| FY2022 | -$173.7M | -18.6% |
| FY2021 | -$146.4M | -19.8% |
| FY2020 | -$122.2M | +3.1% |
| FY2019 | -$126.1M | -100.9% |
| FY2018 | -$62.8M | -112.1% |
| FY2017 | -$29.6M | -21.9% |
| FY2016 | -$24.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice